Diabetes Technology Guideline Resources | Endocrine Society
Clinical Practice Guideline

Diabetes Technology Guideline Resources

September 01, 2016

Full Guideline: Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults
JCEM | September 2016

Anne L. Peters (Chair), Andrew J. Ahmann, Tadej Battelino, Alison Evert, Irl B. Hirsch, M. Hassan Murad, William E. Winter, and Howard Wolpert

The 2016 guideline on Diabetes Technology addresses:

  • Matching individuals to the best-suited technological solutions for type 1 and type 2 diabetes management
  • Deciding when individuals would benefit from continuous subcutaneous insulin infusion (CSII) and real-time continuous glucose monitoring (RT-CGM)
  • Assessing and re-assessing individual psychological status, self-care behavior, and education and training before and during use to ensure adherence and maximize successful adoption of technology




Essential Points

The guideline task force gave its strongest recommendation in support of using CGM technology in individuals with type 1 diabetes who are able and willing to use the monitors. The task force also suggested that CGMs can be used on a short-term, intermittent basis for individuals with type 2 diabetes whose blood glucose is above targeted levels.

The guideline task force also recommended the use of insulin pumps over multiple daily insulin injections in individuals with type 1 diabetes who have not met their A1C goals and are willing and able to use the device. In addition, pumps are recommended for people with frequent hypoglycemia or glucose variability, and those who require increased insulin delivery flexibility or improved satisfaction with their diabetes care. Insulin pump use was suggested for people with type 2 diabetes who were not meeting their glycemic goals.

Summary of Recommendations

+ 1.0 Insulin pump therapy without sensor augmentation

+ 2.0 Insulin pump therapy in type 2 diabetes mellitus

+ 3.0 Insulin pump use in the hospital

+ 4.0 Selection of candidates for insulin pump therapy

+ 5.0 Use of bolus calculators in insulin pump therapy

+ 6.0 Real-time continuous glucose monitors in adult outpatients

On the Go

CPG Mobile App

CPG Mobile App Sample screen
Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Download our CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

On the Go

GUIDELINES Pocket Guides

Pocket Guides
Practical quick-reference tools to help you make accurate clinical decisions at the point of care.

Practical quick-reference tools to help you make accurate clinical decisions at the point of care.

ENDO 2020

Maximize Your Savings

Register Today
Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.

Early Registration Deadline: December 12, 2019

Bringing together leading experts, researchers, and the most respected clinicians in the field, ENDO represents a convergence of science and practice that highlights and facilitates breakthrough discoveries in the field of endocrinology.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!